Your browser doesn't support javascript.
loading
Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study.
Tu, Xinyue; Yang, Jing; Zheng, Yingbin; Liang, Chen; Tao, Qiang; Tang, Xiang; Liu, Zonghao; Jiang, Lingmin; He, Zhaoqian; Xie, Feihu; Zheng, Yun.
Afiliación
  • Tu X; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Yang J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
  • Zheng Y; Department of Gastrointestinal Surgery 2, Meizhou People's Hospital, Meizhou, Guangdong 510060, China.
  • Liang C; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Tao Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Tang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Liu Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Jiang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • He Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Xie F; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
  • Zheng Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, Guangdong 510060, China; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, Chin
Int Immunopharmacol ; 113(Pt B): 109401, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36395672

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article